Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $0.32 in the prior trading day, FibroGen Inc (NASDAQ: FGEN) closed at $0.31, down -3.75%. In other words, the price has decreased by -$3.75 from its previous closing price. On the day, 2.71 million shares were traded. FGEN stock price reached its highest trading level at $0.3361 during the session, while it also had its lowest trading level at $0.304.
Ratios:
Our goal is to gain a better understanding of FGEN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.24 and its Current Ratio is at 1.41.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2023, Downgraded its rating to Underperform and sets its target price to $2 from $4 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 12 ’24 when Adib Deyaa bought 22,123 shares for $1.17 per share. The transaction valued at 25,884 led to the insider holds 82,123 shares of the business.
Wettig Thane bought 50,000 shares of FGEN for $95,470 on Mar 07 ’24. The CEO now owns 470,178 shares after completing the transaction at $1.91 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FGEN now has a Market Capitalization of 32128404 and an Enterprise Value of 95958440. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.18. Its current Enterprise Value per Revenue stands at 0.552 whereas that against EBITDA is -0.579.
Stock Price History:
Over the past 52 weeks, FGEN has reached a high of $2.93, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is -19.43%, while the 200-Day Moving Average is calculated to be -72.34%.
Shares Statistics:
The stock has traded on average 1.63M shares per day over the past 3-months and 1420500 shares per day over the last 10 days, according to various share statistics. A total of 98.77M shares are outstanding, with a floating share count of 93.37M. Insiders hold about 7.00% of the company’s shares, while institutions hold 57.14% stake in the company. Shares short for FGEN as of 1728950400 were 4030293 with a Short Ratio of 2.47, compared to 1726185600 on 4771385. Therefore, it implies a Short% of Shares Outstanding of 4030293 and a Short% of Float of 4.73.
